News

Merck's Verona Acquisition: Plugging A $4B Hole In A $20B Gap
Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent ...
Merck to Buy Verona Pharma in $10 Billion Deal
The move bolsters Merck’s lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.
Verona offer for Candè, Cagliari meeting for Esposito
Verona are in talks for Venezia defender Fali Candè, while Cagliari have met Inter for Sebastiano Esposito, but Fiorentina ...
Verona manager resigns from post
Verona officials will soon be in the market for a new manager. Stefanie Woolford resigned from her position during Tuesday ...
STAT2d
Merck to buy lung-disease biotech Verona Pharma for $10 billion
Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...
Verona Pharma Stock Soars to All-Time High as Merck Buys Firm for $10B
Merck said the deal is valued at $107 per ADS, a 23% premium to Verona’s closing price yesterday.
Explore more
Merck nears about $10 billion deal for London-based lung therapy firm Verona, FT reports
U.S. drugmaker Merck is nearing a deal worth about $10 billion to buy Verona Pharma, a company focused on therapies for lung ...
Merck Buys Verona Pharma: A Good Deal, But M&A Spree Must Continue
Merck & Co., Inc. is acquiring Verona Pharma plc for $10bn to bolster long-term growth with COPD drug Ohtuvayre. Click for my ...
BioPharma Dive2d
Merck to buy Verona and its lung drug in $10B deal
The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.
Merck to Buy Verona for $10 Billion as Patent Cliff Looms
Merck & Co. agreed to buy respiratory drugmaker Verona Pharma Plc for around $10 billion as part of its ongoing search for ...